Article Type
Changed
Mon, 02/18/2019 - 08:16
Display Headline
Should patients receiving long-term gastric acid inhibition therapy be evaluated for vitamin B12 deficiency?
Article PDF
Author and Disclosure Information

Joel E. Richter, MD
Chairman, Department of Gastroenterology, Cleveland Clinic

Address: Joel E. Richter, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195-5245; richtej@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 67(11)
Publications
Topics
Page Number
785, 787
Sections
Author and Disclosure Information

Joel E. Richter, MD
Chairman, Department of Gastroenterology, Cleveland Clinic

Address: Joel E. Richter, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195-5245; richtej@ccf.org

Author and Disclosure Information

Joel E. Richter, MD
Chairman, Department of Gastroenterology, Cleveland Clinic

Address: Joel E. Richter, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195-5245; richtej@ccf.org

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 67(11)
Issue
Cleveland Clinic Journal of Medicine - 67(11)
Page Number
785, 787
Page Number
785, 787
Publications
Publications
Topics
Article Type
Display Headline
Should patients receiving long-term gastric acid inhibition therapy be evaluated for vitamin B12 deficiency?
Display Headline
Should patients receiving long-term gastric acid inhibition therapy be evaluated for vitamin B12 deficiency?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media